Nitric Oxide Donors

"Nitric Oxide Donors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81)

Descriptor ID	D020030
MeSH Number(s)	D27.505.519.656 D27.505.954.411.590
Concept/Terms	Nitric Oxide Donors Nitric Oxide Donors Donors, Nitric Oxide Oxide Donors, Nitric

Below are MeSH descriptors whose meaning is more general than "Nitric Oxide Donors".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Nitric Oxide Donors [D27.505.519.656]
Therapeutic Uses [D27.505.954]
Cardiovascular Agents [D27.505.954.411]
Nitric Oxide Donors [D27.505.954.411.590]

Below are MeSH descriptors whose meaning is related to "Nitric Oxide Donors".

Below are MeSH descriptors whose meaning is more specific than "Nitric Oxide Donors".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Nitric Oxide Donors" by people in this website by year, and whether "Nitric Oxide Donors" was a major or minor topic of these publications.

Bar chart showing 30 publications over 17 distinct years, with a maximum of 5 publications in 2007

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	1	1	2
2001	0	1	1
2002	0	1	1
2003	0	2	2
2004	1	1	2
2005	0	1	1
2006	1	1	2
2007	1	4	5
2008	1	0	1
2010	1	1	2
2011	1	1	2
2012	1	0	1
2013	0	1	1
2014	0	1	1
2015	2	0	2
2017	0	2	2
2018	1	1	2

Below are the most recent publications written about "Nitric Oxide Donors" by people in Profiles.

Singh I, Nath N, Saxena N, Singh AK, Won JS. Regulation of IL-10 and IL-17 mediated experimental autoimmune encephalomyelitis by S-nitrosoglutathione. Immunobiology. 2018 10; 223(10):549-554.

View in: PubMed
Khalaf M, Chowdhary S, Elias PS, Castell D. Distal Esophageal Spasm: A Review. Am J Med. 2018 09; 131(9):1034-1040.

View in: PubMed
Palygin O, Ilatovskaya DV, Levchenko V, Endres BT, Geurts AM, Staruschenko A. Nitric oxide production by glomerular podocytes. Nitric Oxide. 2018 01 30; 72:24-31.

View in: PubMed
Tita C, Gilbert EM, Van Bakel AB, Grzybowski J, Haas GJ, Jarrah M, Dunlap SH, Gottlieb SS, Klapholz M, Patel PC, Pfister R, Seidler T, Shah KB, Zielinski T, Venuti RP, Cowart D, Foo SY, Vishnevsky A, Mitrovic V. A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fraction. Eur J Heart Fail. 2017 10; 19(10):1321-1332.

View in: PubMed
Kaliyaperumal K, Sharma AK, McDonald DG, Dhindsa JS, Yount C, Singh AK, Won JS, Singh I. S-Nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma. Redox Biol. 2015 Dec; 6:41-50.

View in: PubMed
Duan W, Li J, Inks ES, Chou CJ, Jia Y, Chu X, Li X, Xu W, Zhang Y. Design, synthesis, and antitumor evaluation of novel histone deacetylase inhibitors equipped with a phenylsulfonylfuroxan module as a nitric oxide donor. J Med Chem. 2015 May 28; 58(10):4325-38.

View in: PubMed
Seth RK, Das S, Pourhoseini S, Dattaroy D, Igwe S, Ray JB, Fan D, Michelotti GA, Diehl AM, Chatterjee S. M1 polarization bias and subsequent nonalcoholic steatohepatitis progression is attenuated by nitric oxide donor DETA NONOate via inhibition of CYP2E1-induced oxidative stress in obese mice. J Pharmacol Exp Ther. 2015 Jan; 352(1):77-89.

View in: PubMed
Goulopoulou S, Hannan JL, Matsumoto T, Ergul A, Webb RC. Augmented dilation to nitric oxide in uterine arteries from rats with type 2 diabetes: implications for vascular adaptations to pregnancy. Am J Physiol Heart Circ Physiol. 2014 Feb 15; 306(4):H610-8.

View in: PubMed
Paintlia MK, Paintlia AS, Singh AK, Singh I. S-nitrosoglutathione induces ciliary neurotrophic factor expression in astrocytes, which has implications to protect the central nervous system under pathological conditions. J Biol Chem. 2013 Feb 08; 288(6):3831-43.

View in: PubMed
Khan M, Sakakima H, Dhammu TS, Shunmugavel A, Im YB, Gilg AG, Singh AK, Singh I. S-nitrosoglutathione reduces oxidative injury and promotes mechanisms of neurorepair following traumatic brain injury in rats. J Neuroinflammation. 2011 Jul 06; 8:78.

View in: PubMed

People

Explore

Similar Concepts

Top Journals